Search results

Filter

Filetype

Your search for "*" yielded 552653 hits

Projects

The Department of Strategic Communication's research is conducted in individual projects and in broader collaborations, within and outside the department. This is an automatically updated list of the 20 research projects and networks most recently registered in the Lund University Research Portal. For a more detailed register of the department's ongoing, finished and future research projects and n

https://www.isk.lu.se/en/projects - 2026-01-21

Conferences and Workshops

Here you find conferences, workshops, and other activities organised by our researchers. Upcoming eventsEUPRERA Annual congress 2025 - At the Intersection between 
Academia and Practice in Public Relations and Strategic CommunicationPrevious events2023 International Communication Association (ICA) Preconference: Organizing in the Face of Global Crises 2023 IPBA conference: Place branding in times

https://www.isk.lu.se/en/research/conferences-and-workshops - 2026-01-21

Manca Mohar, Masters Student

Current projectMaster´s Thesis project: Role of apolipoprotein A-I an the regulation if insulin secretion from pancreatic beta cells.The aim of this thesis is to explain the biological mechanism by which ApoA-I improves insulin secretion and islet function in an INS1E cell culture model. The project focuses on the determination of ApoA-I action in different steps of glucose stimulated insulin secr

https://www.ludc.lu.se/research-0/medical-protein-science/group-members/manca-mohar-masters-student - 2026-01-21

Oksana Sulaieva, PhD

Current positionProject assistantCurrent projectOksana was graduated from medical university in Ukraine and has a background in histology, cytology, embryology, pathophysiology, pathology, molecular pathology and genetics. Oksana is certified in GCP/GCLP and experienced in clinical trials and project management. Contact: oksana [dot] sulaieva [at] med [dot] lu [dot] se

https://www.ludc.lu.se/valeriya-lyssenko/oksana-sulaieva-phd - 2026-01-21

LUDC-IRC

Almost 0.5 billion people have diabetes globally, many of whom are unaware of their condition; within the next two decades, this number is expected to double, largely owing to a growing, ageing, and increasingly industrialized global population. Lund University receives 100 million SEK from The Swedish Foundation for Strategic Research to help stop this development. Diabetes, a disease caused larg

https://www.ludc.lu.se/about-us/ludc-irc/ludc-irc - 2026-01-21

Marcos Sanches, postdoctoral fellow

BackgroundMarcos came from Brazil, where he completed a PhD in Science at the Department of Structural and Functional Biology at the Federal University of São Paulo. In his PhD research Marcos worked with the role of the Annexin A1 protein in the activation and regulation of the NLRP3 inflammasome in macrophages and neutrophils, as well as in Candida spp. infection. Besides working with molecular

https://www.ludc.lu.se/research-0/metabolic-disorders-and-liver-disease/group-members/marcos-sanches-postdoctoral-fellow - 2026-01-21

About us

Welcome to LUDC Activities - see our calendar Thesis defence, seminars and other activities - see our calendar VIDEO: Ten years of progress, from heterogeneity to personalized treatment Press releases and news Subscribe to our newsletter to stay updated  Meet us Meet the person behind the researcher and read about their research and driving forces VIDEO: A powerhouse for diabetes

https://www.ludc.lu.se/about-us - 2026-01-21

Contact

For general enquiries, please contact administrative coordinator Ulrika Blom-Nilsson. Ulrika Blom-NilssonAdministrative Coordinatorulrika [dot] blom-nilsson [at] med [dot] lu [dot] se+46 (0)76 803 99 72+46 (0)40 39 12 01 Allan VaagProfessor and Coordinator of LUDC and EXODIABallan [dot] vaag [at] med [dot] lu [dot] seLena EliassonProfessor and Vice Coordinator of LUDC and EXODIABlena [dot] eliasso

https://www.ludc.lu.se/contact - 2026-01-21

Christina-Alexandra Schulz

The role of circulating biomarkers, genetics, and diet in kidney function Today, between 8% and 16% of all individuals worldwide suffer from chronic kidney disease (CKD), which is becoming a growing public health issue. Creatinine and cystatin C are commonly used markers for kidney function, and estimated glomerular filtration rate (eGFR) and albuminuria are used to stage CKD. However, creatinine

https://www.ludc.lu.se/education-training/theses/theses-2017/christina-alexandra-schulz - 2026-01-21

Supplementary material

Additional material for LUDC publications Plasma concentration of proneurotensin and prediction of cause-specific mortality in a middle-aged cohort during long-term follow-up Ayesha Fawad1, Andreas Bergmann2, Joachim Struck2, Zahra A. Butt3, Peter M Nilsson1, Louise Bennet1, Marju Orho-Melander1, and Olle Melander1 Lund University, Department of Clinical Sciences, Malmo, Sweden Sphingotec GmbH, He

https://www.ludc.lu.se/resources/supplementary-material - 2026-01-21

List of all prize winners

Year, name and affiliation 2022 Myriam Aouadi, Associate Professor, Karolinska Institute, Centre for infectious Medicine, Stockholm 2021 Stefano Romeo, Professor, Sahlgrenska Akademym, Dept of Molecular and Clinical Medicine, Gothenburg   2020 Niels Grarup, Associate Professor, Copenhagen University, Denmark 2019 Olov Andersson, Professor. Karolinska Institute, Stockholm 2018 Jorge Lira Ruas, Asso

https://www.ludc.lu.se/about-us/diabetes-programme-lund-university-dplu/leif-c-groop-award-outstanding-diabetes-research/list-all-prize-winners - 2026-01-21

Lund University Diabetes Centre

Excellence of diabetes research Read about EXODIAB Industrial research centre Read about LUDC-IRC Quick links Work for usLUDC Early Career NetworkCourses and training  Research Research facilities and specialist expertise Explore our facilities and specialist expertise which support our researchers in their  projects and collaborations.  Support diabetes research at LUDC Lund University Diabetes C

https://www.ludc.lu.se/home - 2026-01-21

Diabetes – Epigenetics

Charlotte Ling’s group Our researchThe goal of our research is to dissect the role of epigenetics in the pathogenesis of type 2 diabetes and develop epigenetic-based therapies and biomarkers for precision medicine.Type 2 diabetes is a multifactorial disease, and combinations of genetic and non-genetic factors such as age, obesity, and physical inactivity increase disease risk. Data from our group

https://www.ludc.lu.se/research/diabetes-epigenetics - 2026-01-21